Current studentsExisting staffContact us
 

Therapeutic effects and possible mechanisms of a snake venom preparation in the fibrotic rat liver

Simple item page
dc.contributor.authorChang, P.
dc.contributor.authorHung, D.
dc.contributor.authorSiebert, G.
dc.contributor.authorBridle, K.
dc.contributor.authorRoberts, M.S.
dc.date.issued2005
dc.description.abstractThe effects of a Chinese snake venom preparation from Agkistrodon halys pallas, used for treatment of hepatic fibrosis/cirrhosis in China, was investigated in an in vivo rat model and using in situ hepatic perfusion. Four groups were used in the experiments: (i) healthy, (ii) healthy/venom-treated, (iii) carbon tetrachloride (CCl4)-treated, and (iv) CCl4/venom-treated. Treatment effects were assessed by determining hepatic histopathology, biochemistry and fibrosis index parameters, bile production, biliary taurocholate recovery, hepatic mRNA expression of four bile salt transporters (Ntcp, Bsep, Oatp-1, and Oatp-3), comparison of hepatic microcirculation, fibrinolytic activity, and antithrombotic effects. Liver histopathology, biochemistry, and fibrosis index showed a dramatic improvement in venom-treated animals. There were significant differences in bile production between healthy/venom-treated and all other experimental groups and between CCl4/venom-treated and CCl4-treated animals, but no significant differences were found between CCl4/venom-treated and healthy animals. Biliary taurocholate recovery was significantly increased in healthy/venom-treated and CCl4/venom-treated animals. The expression of mRNA levels of the four bile salt transporters showed an increase after venom treatment. The hepatic microcirculation studies showed normalized sinusoidal beds in CCl4/venom-treated animals compared to healthy animals, whereas CCl4-treated animals showed abnormal profiles to the healthy and the CCl4/AHPV-treated animals. The fibrinogen and plasma thromboxane B2 levels of healthy rats decreased with increasing dose after venom treatment. It was concluded that snake venom treatment may be therapeutic in treatment of hepatic fibrosis/cirrhosis by possibly a combination of increased bile flow and improved hepatic microcirculation, changes in bile salt transporter expression, and fibrinolytic and antithrombotic effects of the snake venom preparation.
dc.identifier.citationDigestive Diseases and Sciences, 2005; 50(4):745-752
dc.identifier.doi10.1007/s10620-005-2567-z
dc.identifier.issn0163-2116
dc.identifier.issn1573-2568
dc.identifier.urihttps://hdl.handle.net/1959.8/136858
dc.language.isoen
dc.publisherSpringer
dc.relation.grantNHMRC
dc.source.urihttps://doi.org/10.1007/s10620-005-2567-z
dc.subjectcirrhosis - snake venom - bile salt transporters - fibrinolysis - antithrombotic
dc.titleTherapeutic effects and possible mechanisms of a snake venom preparation in the fibrotic rat liver
dc.typeJournal article
pubs.publication-statusPublished
ror.mmsid9915911740201831

Files

Collections